Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”

Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”

Orthotopic glioblastoma xenografts are paramount for evaluating the effect of innovative anti-cancer treatments. In longitudinal studies, tumor growth (or regression) of glioblastoma can only be monitored by noninvasive imaging. For this purpose, bioluminescence imaging (BLI) has gained popularity b...

Full description

Bibliographic Details
Main Authors: Mathilde Bausart, Elia Bozzato, Nicolas Joudiou, Xanthippi Koutsoumpou, Bella Manshian, Véronique Préat, Bernard Gallez
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
glioblastoma
GL261
luciferase
bioluminescence imaging
magnetic resonance imaging
optical imaging
Online Access:https://www.mdpi.com/2072-6694/15/6/1919

Internet

https://www.mdpi.com/2072-6694/15/6/1919

Similar Items